Contract awardedElectronic signature software

Adobe Sign renewed for a year at Cell and Gene Therapy Catapult

Cell and Gene Therapy Catapult has renewed its licence and support for Adobe Sign, its electronic signature software. The catapult uses it across the organisation to approve contracts and other corporate papers. The catapult describes the software as business-critical.

The catapult awarded the £17,400 renewal directly to Adobe in September 2026, without a competition. The licence runs for 12 months, to September 2027.

Alert me to similar tenders

Contract ends September 2027

What
Electronic signature software
Supplier
Adobe
Value
£17,400
How it was bought
Below threshold - without competition
Dates and next
Sep 2026 to Sep 2027

How it was bought

1 official notice
  1. 25 Sep 2026Contract starts
  2. 30 Sep 2026Award noticeFind a Tender
  3. 24 Sep 2027Contract ends

How it compares

With every electronic signature software award since 2021

Half of awards fall between £20,211 and £57,051Median £35,600

Awards
136
Firms that won them
32
Median award
£35,600
of 126 with a value
This award
Smaller than 79%
of them
Typical length
2 years
In London
24 awards

Adobe ranks 8th of 32 firms for electronic signature software awards since 2021.

RankFirmAwardsValue
1Locked60£2.49m
2Locked13£629,426
3Locked6£540,842
3Locked6£259,978
5Locked5£307,289
6Locked4£187,325
8Adobe Won this one3£208,282
See who wins this work

Figures to 21 November 2026

Electronic signature software at other buyers

Cell and Gene Therapy Catapult has awarded 121 contracts since 2021.

See Cell and Gene Therapy Catapult's page
  • Adobe has won 16 public contracts since 2021.